TempoLife › Features › Premenstrual dysphoric disorder and prospective tracking
Premenstrual dysphoric disorder and prospective tracking: premenstrual dysphoric disorder and prospective tracking. This source-reviewed orientation page…
This guide is general education, not a diagnosis or an individual treatment plan. Urgent, severe or worsening symptoms belong with the local emergency service or a qualified clinician.
Premenstrual dysphoric disorder and prospective tracking. This source-reviewed orientation page separates stable record-the-onset-pattern-timing-trigger-location-function-medicine-and-effect-on-life principles from decisions that depend on examination, imaging, cycle and symptom diaries, nerve studies, pregnancy and fertility goals, menopause status, family history, red flags, exercise capacity, exact diagnosis and direct professional assessment. The named editions, URLs and reuse limits were checked on 2026-09-11.
It remains outside search indexes pending a second-person clinical editorial review and localisation.
Start with the description that most closely matches your question about Premenstrual dysphoric disorder and prospective tracking. Use the evidence section to understand what is known, then use the boundary section to decide when self-education should stop and clinical care should begin.
The page keeps the main question, its evidence base and its limits together in one canonical place. That makes it useful as a quick orientation and avoids splitting a broad subject into shallow pages before each narrower answer has enough verified material of its own.
These concise notes are independently written from the source set below. In an emergency, use the local emergency number and follow the dispatcher rather than relying on a static page.
Premenstrual dysphoric disorder is a severe cyclical condition affecting mood, work and relationships, with symptoms appearing in the luteal phase and settling after the period. It differs from mild PMS by the degree of distress and impairment, and from depression or anxiety by its timing across the cycle. A two-cycle daily symptom diary is the key diagnostic tool, ahead of any questionnaire alone.
Sources for this note: Premenstrual Syndrome, Management (Green-top Guideline No. 48); PMDD (premenstrual dysphoric disorder).
Lifestyle and supportive measures, psychological therapy, hormone treatment and some antidepressants are used in steps, but the sequence depends on contraception needs, fertility wishes, other health conditions and medicine interactions. Never change an antidepressant or hormone prescription without the prescriber. The RCOG guideline uses the diary to match the treatment step, so keep the record while treatment is being adjusted.
Sources for this note: Premenstrual Syndrome, Management (Green-top Guideline No. 48); PMDD (premenstrual dysphoric disorder).
Terminology changes across borders. These are example phrases people use for the same subject in Estonian, Finnish, Russian and English; they are included as a practical vocabulary aid, not as hidden keywords.
| Language | Example phrase |
|---|---|
| Estonian | PMDD sümptomid |
| Finnish | PMDD oireet |
| Russian | ПМДР симптомы |
| English | PMDD symptom tracking |
Authoritative source editions, URLs, scope and reuse limits were checked on 11 September 2026. The bacterial-vaginosis, endometriosis, fibroids, ovarian-cyst, PMDD, neck-pain, shoulder, tennis-elbow, wrist-pain and carpal-tunnel notes are independently paraphrased and remain noindex pending second-person gynaecology, sexual-health, orthopaedic, physiotherapy, pharmacy and Estonia/Finland localisation review.
Publisher: Royal College of Obstetricians and Gynaecologists
Edition: RCOG Green-top Guideline No. 48; current page checked 11 September 2026
Reuse decision: RCOG content is protected by copyright and no general reuse licence is assumed. TempoLife links and independently paraphrases only the symptom-diary and stepped-treatment boundaries; no algorithm is reproduced.
Publisher: NHS
Edition: Current patient guidance checked 11 September 2026
Reuse decision: NHS website terms apply. TempoLife links and independently paraphrases limited symptom, diary and treatment boundaries; it does not make a diagnosis or change a medicine.
Source URLs and reuse terms checked: 2026-09-11. This date is not a guarantee that an external source has remained unchanged.
This source-review release verifies the named editions, URLs, scope and reuse limits for the orientation page.
It remains outside search indexes: it is not a gynaecological, sexual-health, orthopaedic, nerve or pain diagnosis; an ultrasound, symptom-diary, nerve-study or imaging interpretation; a hormone, antidepressant, injection or surgery decision; an exercise prescription; or a substitute for urgent local care, the exact medicine label and direct assessment by the person’s own clinician, pharmacist, physiotherapist, gynaecology, orthopaedic or pain service.
The following paths are the intentional hand-offs named in the brief. They keep adjacent subjects separate while making the next useful reference easy to find.
/cycle.
Premenstrual dysphoric disorder and prospective tracking. This source-reviewed orientation page separates stable record-the-onset-pattern-timing-trigger-location-function-medicine-and-effect-on-life principles from decisions that depend on examination, imaging, cycle and symptom diaries, nerve studies, pregnancy and fertility goals, menopause status, family history, red flags, exercise capacity, exact diagnosis and direct professional assessment. The named editions, URLs and reuse limits were checked on…
Reviewed source set (checked 2026-09-11): Premenstrual Syndrome, Management (Green-top Guideline No. 48); PMDD (premenstrual dysphoric disorder).
This source-review release verifies the named editions, URLs, scope and reuse limits for the orientation page. It remains outside search indexes: it is not a gynaecological, sexual-health, orthopaedic, nerve or pain diagnosis; an ultrasound, symptom-diary, nerve-study or imaging interpretation; a hormone, antidepressant, injection or surgery decision; an exercise prescription; or a substitute for urgent local care, the exact medicine label and direct assessment by the person’s own clinician, pharmacist…
TempoLife brings food, movement, sleep and everyday health habits into one private place when you want to track what happens next.
